Annovis Bio Gets NYSE Noncompliance Notice

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Annovis Bio Gets NYSE Noncompliance Notice

, MT Newswires - 5:36 PM ET 3/27/2025 default

05:36 PM EDT, 03/27/2025 (MT Newswires) -- Annovis Bio ( ANVS ) said Thursday it has received a noncompliance notice from the New York Stock Exchange for market capitalization and stockholders' equity both below $50 million for 30 consecutive days.

It has notified the NYSE of its intention to submit a plan within 45 days detailing how it plans to regain listing compliance in the next 18 months, the company said in a statement.

The notice does not impact the company's operations or reporting obligations with the US Securities and Exchange Commission.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.